C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 2 151.05 INR 0.71% Market Closed
Market Cap: 225B INR
Have any thoughts about
Concord Biotech Ltd?
Write Note

Intrinsic Value

The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 126.37 INR. Compared to the current market price of 2 151.05 INR, Concord Biotech Ltd is Overvalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CONCORDBIO Intrinsic Value
1 126.37 INR
Overvaluation 48%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Concord Biotech Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CONCORDBIO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CONCORDBIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about CONCORDBIO?
Bearish
Neutral
Bullish

Fundamental Analysis

2 151.05 INR
+0.71%
+0.71%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Concord Biotech Ltd
IN
Pharmaceuticals
Market Cap
225B INR
IPO
Aug 18, 2023
Employees
-
India
Market Cap
225B INR
Industry
Pharmaceuticals
IPO
Aug 18, 2023
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Concord Biotech Ltd

Provide an overview of the primary business activities
of Concord Biotech Ltd.

What unique competitive advantages
does Concord Biotech Ltd hold over its rivals?

What risks and challenges
does Concord Biotech Ltd face in the near future?

Has there been any significant insider trading activity
in Concord Biotech Ltd recently?

Summarize the latest earnings call
of Concord Biotech Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Concord Biotech Ltd.

Provide P/S
for Concord Biotech Ltd.

Provide P/E
for Concord Biotech Ltd.

Provide P/OCF
for Concord Biotech Ltd.

Provide P/FCFE
for Concord Biotech Ltd.

Provide P/B
for Concord Biotech Ltd.

Provide EV/S
for Concord Biotech Ltd.

Provide EV/GP
for Concord Biotech Ltd.

Provide EV/EBITDA
for Concord Biotech Ltd.

Provide EV/EBIT
for Concord Biotech Ltd.

Provide EV/OCF
for Concord Biotech Ltd.

Provide EV/FCFF
for Concord Biotech Ltd.

Provide EV/IC
for Concord Biotech Ltd.

Show me price targets
for Concord Biotech Ltd made by professional analysts.

What are the Revenue projections
for Concord Biotech Ltd?

How accurate were the past Revenue estimates
for Concord Biotech Ltd?

What are the Net Income projections
for Concord Biotech Ltd?

How accurate were the past Net Income estimates
for Concord Biotech Ltd?

What are the EPS projections
for Concord Biotech Ltd?

How accurate were the past EPS estimates
for Concord Biotech Ltd?

What are the EBIT projections
for Concord Biotech Ltd?

How accurate were the past EBIT estimates
for Concord Biotech Ltd?

Compare the revenue forecasts
for Concord Biotech Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Concord Biotech Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Concord Biotech Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Concord Biotech Ltd compared to its peers.

Compare the P/E ratios
of Concord Biotech Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Concord Biotech Ltd with its peers.

Analyze the financial leverage
of Concord Biotech Ltd compared to its main competitors.

Show all profitability ratios
for Concord Biotech Ltd.

Provide ROE
for Concord Biotech Ltd.

Provide ROA
for Concord Biotech Ltd.

Provide ROIC
for Concord Biotech Ltd.

Provide ROCE
for Concord Biotech Ltd.

Provide Gross Margin
for Concord Biotech Ltd.

Provide Operating Margin
for Concord Biotech Ltd.

Provide Net Margin
for Concord Biotech Ltd.

Provide FCF Margin
for Concord Biotech Ltd.

Show all solvency ratios
for Concord Biotech Ltd.

Provide D/E Ratio
for Concord Biotech Ltd.

Provide D/A Ratio
for Concord Biotech Ltd.

Provide Interest Coverage Ratio
for Concord Biotech Ltd.

Provide Altman Z-Score Ratio
for Concord Biotech Ltd.

Provide Quick Ratio
for Concord Biotech Ltd.

Provide Current Ratio
for Concord Biotech Ltd.

Provide Cash Ratio
for Concord Biotech Ltd.

What is the historical Revenue growth
over the last 5 years for Concord Biotech Ltd?

What is the historical Net Income growth
over the last 5 years for Concord Biotech Ltd?

What is the current Free Cash Flow
of Concord Biotech Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Concord Biotech Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Concord Biotech Ltd

Balance Sheet Decomposition
Concord Biotech Ltd

Current Assets 9.3B
Cash & Short-Term Investments 3.2B
Receivables 3.4B
Other Current Assets 2.7B
Non-Current Assets 8.3B
Long-Term Investments 95.5m
PP&E 8.1B
Intangibles 7.8m
Other Non-Current Assets 133.3m
Current Liabilities 1.4B
Accounts Payable 821.7m
Other Current Liabilities 595.4m
Non-Current Liabilities 322.5m
Long-Term Debt 16.1m
Other Non-Current Liabilities 306.5m
Efficiency

Earnings Waterfall
Concord Biotech Ltd

Revenue
10.9B INR
Cost of Revenue
-2.6B INR
Gross Profit
8.3B INR
Operating Expenses
-4.2B INR
Operating Income
4B INR
Other Expenses
-765m INR
Net Income
3.3B INR

Free Cash Flow Analysis
Concord Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CONCORDBIO Profitability Score
Profitability Due Diligence

Concord Biotech Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Operating Income
68/100
Profitability
Score

Concord Biotech Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

CONCORDBIO Solvency Score
Solvency Due Diligence

Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CONCORDBIO Price Targets Summary
Concord Biotech Ltd

Wall Street analysts forecast CONCORDBIO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 2 025.38 INR with a low forecast of 1 737.2 INR and a high forecast of 2 296.35 INR.

Lowest
Price Target
1 737.2 INR
19% Downside
Average
Price Target
2 025.38 INR
6% Downside
Highest
Price Target
2 296.35 INR
7% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CONCORDBIO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CONCORDBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CONCORDBIO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one CONCORDBIO stock?

The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 126.37 INR.

Is CONCORDBIO stock undervalued or overvalued?

Compared to the current market price of 2 151.05 INR, Concord Biotech Ltd is Overvalued by 48%.

Back to Top